SentreHEART is a medical device company that manufacturers the LARIAT Suture Delivery Device for remote delivery of a pre-tied suture loop. Innovation in catheter and suture delivery technology enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind.
Type
Private
HQ
Redwood City, US
Founded
2005
Size (employees)
36 (est)-2%
SentreHEART was founded in 2005 and is headquartered in Redwood City, US
Report incorrect company information

Key People/Management at SentreHEART

Paul Buckman

Paul Buckman

President & CEO
William E Cohn

William E Cohn

Founder

SentreHEART Office Locations

SentreHEART has an office in Redwood City
Redwood City, US (HQ)
300 Saginaw Dr
Show all (1)
Report incorrect company information

SentreHEART Financials and Metrics

Summary Metrics

Founding Date

2005

Total Funding

$69 m

Latest funding size

$35 m

Time since last funding

2 years ago

Investors

SentreHEART's latest funding round in September 2016 was reported to be $35 m. In total, SentreHEART has raised $69 m
Show all financial metrics
Report incorrect company information

SentreHEART News and Updates

Impact of Existing and Emerging Atrial Appendage Occluder Market Trends 2017-2027

Future Market Insights has announced the addition of the “Atrial Appendage Occluder Market: Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Left Atrial Appendage (LAA) Closure Devices Market Size will Escalate Rapidly in the Near Future

The global left atrial appendage (LAA) closure devices market is expected to register a significant CAGR over a forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information